Product Description
Brand Mindray
Sample Type Serum
Pack Size 2 x 50T, 2 x 100T
CAT No 10500421300, 10500424000
Application Immuno-Assay
Ourchemiluminescence immunoassay reagentshave been specially developed to work with Mindray's CL series automatic chemiluminescence immunoassay analyzers to make a complete system, offering high reliability and accuracy. Mindray uses liquid, ready-to-use reagents which come in two packages, 50 tests and 100 tests, to suit customers with different requirements.
Advanced Tumor Marker DetectionMindray's CEA CLIA Reagent Kit supports laboratories in identifying and monitoring various cancers, including colorectal, lung, and breast tumors. Its robust chemiluminescence immunoassay (CLIA) technology delivers quantitative and highly accurate CEA measurements, aiding clinicians in evaluating disease progression or recurrence effectively.
Simple, Automated WorkflowTailored for use with Mindray CL-900i, CL-1000i, and compatible CL-series analyzers, the kit offers approximate 15-minute test times per sample, facilitating efficient laboratory operation. All-in-one packaging, including controls and calibrators, minimizes preparation time and supports reliable, automated results.
Precision and ComplianceThis CE-marked, IVD-certified kit ensures professional-grade diagnostic performance with robust traceability for every lot. Designed for refrigerated storage (2-8C) and single-use, it upholds quality and reliability throughout its 12-18 month shelf life, assisting clinical settings in meeting stringent diagnostic standards.
FAQ's of Mindray Carcinoembryonic Antigen (CLIA):
Q: How is the CEA CLIA reagent kit used in laboratory diagnostics?
A: The kit is intended for the quantitative detection of carcinoembryonic antigen (CEA) in human serum or plasma. It is used by professional laboratory staff with compatible Mindray CL-series analyzers, making it suitable for cancer screening, diagnosis, and monitoring.
Q: What sample types can be processed with this kit?
A: The Mindray CEA CLIA kit is validated for use with human serum or plasma samples, ensuring compatibility with routine laboratory blood specimens.
Q: When should results from this kit be used in clinical practice?
A: Results should be used to support cancer diagnosis, assess treatment efficacy, or monitor disease recurrence in patients. The quantitative nature of the assay allows clinicians to track changes in CEA levels over time.
Q: Where should the reagent kit be stored for optimal stability?
A: The kit should be stored refrigerated at 2-8C, away from direct light, and should not be frozen, as this preserves reagent integrity and accuracy throughout its shelf life.
Q: What is the process for running a CEA test using this kit?
A: Prepare the Mindray analyzer as instructed, load the sample and reagents, and allow for automated operation. The test typically takes approximately 15 minutes per sample, with the analyzer providing precise, quantitative CEA results.
Q: What are the benefits of this kit's design and technology?
A: The CLIA technology offers high sensitivity and precise quantification, while the ready-to-use kit format and automated workflow reduce manual handling and error. Lot-specific documentation ensures traceability, supporting quality assurance in clinical laboratories.
Q: Is the kit compatible with all laboratory analyzers?
A: The kit is specifically designed for use with Mindray CL-900i, CL-1000i, and compatible CL-series analyzers. It may not be suitable for other brands or non-compatible equipment.